Latest Blog Posts Tagged "Pathophysiology"
January 17, 2017
Sarkis Mazmanian, PhD, of CalTech discusses what we know about the gut bacteria and Parkinson's connection in our "Getting to a Cure: The Science behind the Search" podcast series.
May 29, 2015
Earlier this year MJFF launched two programs investigating the unknowns around alpha-synuclein, our most promising target for a disease-modifying therapy.
June 13, 2014
A new study shows two avenues through which inhibiting the function of the protein LRRK2 may help treat people with Parkinson's, even those without a LRRK2 genetic mutation.
July 11, 2012
Induced pluripotent stem (iPS) cells respond differently to drugs according to the specific type of Parkinson's disease (PD) a person has.